home2018-09-29T21:24:49+00:00
Unlocking
the medical
potential that
cannabis holds

Nextage Accelerator
Program

READ MORE

Co”LAB”orating
co-working laboratories

READ MORE

Product development & GMP testing and manufacturing

READ MORE

About
Nextage Innovation

Bring together the ingenuity of researchers and startup with the know how of pharmaceutical organizations to create ground breaking quality responsible products and solutions

Born out of Nextar, Israel’s leading CDMO for the development and manufacturing of pharmaceuticals and medical devices, Nextage Innovation is the world’s first “All Inclusive” innovation center for cannabis based products.
Holding a first of its kind license from the Israeli MOH  for the development, testing and manufacturing (GMP) of cannabis products positions Nextage as an industry trailblazer.
The Nextage Innovation Accelerator is an R&D focused program designed to create a place where innovation and experience meet to unlock the potential that cannabis holds.

The Team

ALL TEAM & MENTORS

Orna Dreazen, Ph.d Dipl. BA
Chairperson of the Board

With a Ph.D. in Biochemistry from Weizmann Institute followed by post doctoral studies at UCLA and complemented by a diploma in Business administration from Tel-Aviv University, Dr. Dreazen has An illustrious career that encompassed senior positions in the public and private sectors. From pharmaceutical startups to senior roles in the Ministry of Health and Israel’s accreditation authority to substantial positions at international organizations. Dr. Dreazen is a world expert in Quality,  Metrology and product development.

Abraham Dreazen
CEO

Abraham Dreazen is an architect, entrepreneur and founder and CEO of Nextage Innovation. After building his career in NYC Abraham has joined Nextar chempharma solutions, Israel’s leading pharmaceutical CDMO to establish Nextage Innovation.

Marilyn A. Huestis
Professor Dr. Dr. (h.c.)
Head of advisory board

Professor Dr. Dr. (h.c.) Marilyn A. Huestis recently retired as a tenured senior investigator and Chief, Chemistry and Drug Metabolism Section, at NIDA, National Institutes of Health. She currently is a Senior Fellow at the Institute on Emerging Health Professions, Thomas Jefferson University and on the Steering Committee of The Lambert Center for the Study of Medicinal Cannabis and Hemp, Thomas Jefferson Medical School. Professor Hustis is the President of Huestis & Smith Toxicology, LLC.

Our Partners

From the Media

MORE FROM THE MEDIA

Nextage Innovation Center

You are welcome to visit us at our offices to learn more

Contact us

If you need more information,
you can contact us:

Phone : 073-224-4440
Fax : 073-224-4445

Email :
info@NextageInnovation.com

Einstein St. Building 13B ,Weizmann Science Park
POB 4147 Ness Ziona 74140, Israel